115 related articles for article (PubMed ID: 18459158)
21. High expression of HER3 is associated with a decreased survival in gastric cancer.
Hayashi M; Inokuchi M; Takagi Y; Yamada H; Kojima K; Kumagai J; Kawano T; Sugihara K
Clin Cancer Res; 2008 Dec; 14(23):7843-9. PubMed ID: 19047113
[TBL] [Abstract][Full Text] [Related]
22. Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer.
Yu J; Cheng YY; Tao Q; Cheung KF; Lam CN; Geng H; Tian LW; Wong YP; Tong JH; Ying JM; Jin H; To KF; Chan FK; Sung JJ
Gastroenterology; 2009 Feb; 136(2):640-51.e1. PubMed ID: 19084528
[TBL] [Abstract][Full Text] [Related]
23. Expression levels of cyclin G2, but not cyclin E, correlate with gastric cancer progression.
Choi MG; Noh JH; An JY; Hong SK; Park SB; Baik YH; Kim KM; Sohn TS; Kim S
J Surg Res; 2009 Dec; 157(2):168-74. PubMed ID: 19559447
[TBL] [Abstract][Full Text] [Related]
24. [Tissue array analysis of the aberrant expression of HLA class I molecules in human non small cell lung cancer].
Suzuki H; Higuchi M; Hasegawa T; Yonechi A; Ohsugi J; Yamada F; Hoshino M; Shio Y; Fujiu K; Gotoh M
Gan To Kagaku Ryoho; 2006 Nov; 33(12):1713-6. PubMed ID: 17212084
[TBL] [Abstract][Full Text] [Related]
25. Loss of RUNX3 expression correlates with differentiation, nodal metastasis, and poor prognosis of gastric cancer.
Hsu PI; Hsieh HL; Lee J; Lin LF; Chen HC; Lu PJ; Hsiao M
Ann Surg Oncol; 2009 Jun; 16(6):1686-94. PubMed ID: 19290488
[TBL] [Abstract][Full Text] [Related]
26. Arp2/3 overexpression contributed to pathogenesis, growth and invasion of gastric carcinoma.
Zheng HC; Zheng YS; Li XH; Takahashi H; Hara T; Masuda S; Yang XH; Guan YF; Takano Y
Anticancer Res; 2008; 28(4B):2225-32. PubMed ID: 18751399
[TBL] [Abstract][Full Text] [Related]
27. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.
Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH
Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas.
Zheng HC; Takahashi H; Li XH; Hara T; Masuda S; Guan YF; Takano Y
Hum Pathol; 2008 Jul; 39(7):1042-9. PubMed ID: 18482745
[TBL] [Abstract][Full Text] [Related]
29. Clinical-pathological implication of human leukocyte antigen-F-positive gastric adenocarcinoma.
Ishigami S; Arigami T; Setoyama T; Okumura H; Sasaki K; Uchikado Y; Kurahara H; Kijima Y; Nishizono Y; Nakajo A; Natsugoe S
J Surg Res; 2013 Oct; 184(2):802-6. PubMed ID: 23706560
[TBL] [Abstract][Full Text] [Related]
30. HLA-E and HLA-G expression in classical HLA class I-negative tumors is of prognostic value for clinical outcome of early breast cancer patients.
de Kruijf EM; Sajet A; van Nes JG; Natanov R; Putter H; Smit VT; Liefers GJ; van den Elsen PJ; van de Velde CJ; Kuppen PJ
J Immunol; 2010 Dec; 185(12):7452-9. PubMed ID: 21057081
[TBL] [Abstract][Full Text] [Related]
31. Analysis of human lymphocyte antigen class I expression in gastric cancer by reverse transcriptase-polymerase chain reaction.
Dutta N; Majumder D; Gupta A; Mazumder DN; Banerjee S
Hum Immunol; 2005 Feb; 66(2):164-9. PubMed ID: 15695002
[TBL] [Abstract][Full Text] [Related]
32. Clinical significance of loss of Fhl1 expression in human gastric cancer.
Sakashita K; Mimori K; Tanaka F; Kamohara Y; Inoue H; Sawada T; Hirakawa K; Mori M
Ann Surg Oncol; 2008 Aug; 15(8):2293-300. PubMed ID: 18465173
[TBL] [Abstract][Full Text] [Related]
33. [Relationship between the expression of human leukocyte antigen-b in peripheral blood leukocytes and the differentiation and metastasis of gastric carcinoma].
Zhang Y; Zou X; Yang XJ; Li XL; Zhao SM; Gao YJ
Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):49-52. PubMed ID: 17575694
[TBL] [Abstract][Full Text] [Related]
34. Tumor-associated macrophage (TAM) infiltration in gastric cancer.
Ishigami S; Natsugoe S; Tokuda K; Nakajo A; Okumura H; Matsumoto M; Miyazono F; Hokita S; Aikou T
Anticancer Res; 2003; 23(5A):4079-83. PubMed ID: 14666722
[TBL] [Abstract][Full Text] [Related]
35. Survival of ovarian cancer patients overexpressing the tumour antigen p53 is diminished in case of MHC class I down-regulation.
Leffers N; Lambeck AJ; de Graeff P; Bijlsma AY; Daemen T; van der Zee AG; Nijman HW
Gynecol Oncol; 2008 Sep; 110(3):365-73. PubMed ID: 18571704
[TBL] [Abstract][Full Text] [Related]
36. [Expression of phosphatase of regenerating liver-3 in gastric cancer, its relationship with prognosis, and its role in gastric cancer cell proliferation].
Cai SR; Chen CQ; Wang Z; He YL; Cui J; Wu WH; Wu H; Zhan WH
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(33):2326-30. PubMed ID: 19087692
[TBL] [Abstract][Full Text] [Related]
37. microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells.
Bandres E; Bitarte N; Arias F; Agorreta J; Fortes P; Agirre X; Zarate R; Diaz-Gonzalez JA; Ramirez N; Sola JJ; Jimenez P; Rodriguez J; Garcia-Foncillas J
Clin Cancer Res; 2009 Apr; 15(7):2281-90. PubMed ID: 19318487
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical evaluation of the tumor neoangiogenesis as a prognostic factor for gastric cancers.
Lazăr D; Tăban S; Raica M; Sporea I; Cornianu M; Goldiş A; Vernic C
Rom J Morphol Embryol; 2008; 49(2):137-48. PubMed ID: 18516318
[TBL] [Abstract][Full Text] [Related]
39. Chemokine receptor CXCR4 expression, function, and clinical implications in gastric cancer.
Lee HJ; Kim SW; Kim HY; Li S; Yun HJ; Song KS; Kim S; Jo DY
Int J Oncol; 2009 Feb; 34(2):473-80. PubMed ID: 19148483
[TBL] [Abstract][Full Text] [Related]
40. [Clinical immunogenetics of stomach cancer in Western Siberia].
Konenkov VI; Arshba GA; Korotkova II; Prokof'ev VF; Egorov DN; Vardosanidze KV
Vopr Onkol; 1997; 43(3):269-72. PubMed ID: 9245080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]